Name: AN2 Therapeutics, Inc. (ANTX) Balance Sheet
Creator: FinSpry

AN2 Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for AN2 Therapeutics, Inc. (ANTX) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	21.35	15.65	27.22	12.10	4.07
Short-Term Investments	62.27	91.65	68.84	46.46	0.00
Cash & Short-Term Investments	83.62	107.30	96.06	58.56	4.07
Accounts Receivable	0.30	1.40	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	2.34	3.21	2.56	1.55	0.16
Total Current Assets	86.26	110.51	98.62	60.11	4.23
Non-Current Assets
Property, Plant & Equipment (Net)	0.00	0.00	0.00	0.00	0.00
Long-Term Investments	5.02	27.19	3.22	3.49	0.00
Other Non-Current Assets	0.80	1.04	0.72	0.00	0.00
Total Non-Current Assets	5.83	28.24	3.94	5.21	0.00
Total Assets	92.09	138.74	102.56	65.32	4.23
Current Liabilities
Accounts Payable	3.32	2.68	2.12	1.06	0.13
Accrued Liabilities	6.13	6.68	2.84	2.00	1.31
Other Current Liabilities	0.79	0.67	0.01	0.33	0.01
Total Current Liabilities	10.24	14.04	7.19	3.40	1.46
Non-Current Liabilities
Long-Term Debt	0.00	0.00	0.00	0.00	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.01	0.02
Total Non-Current Liabilities	0.00	0.00	0.00	0.01	0.00
Total Liabilities	10.24	14.04	7.19	3.41	1.48
Stockholders' Equity
Retained Earnings	-205.78	-154.46	-89.72	-47.38	-20.32
Accumulated Other Comprehensive Income	0.03	0.28	-0.37	-0.03	0.00
Additional Paid-in Capital	287.59	278.88	185.47	0.00	0.00
Shares Outstanding	29.92	29.74	19.40	18.71	0.00
Total Stockholders' Equity	81.85	124.70	95.37	61.91	2.75
Total Liabilities & Equity	92.09	138.74	102.56	65.32	0.00